Human Brain Organoids Transplanted Into Rats Respond to Visual Stimuli

The organoids could one day be used to treat brain injuries in humans.

A black and white headshot of Katherine Irving
| 3 min read
an image of a slice of a rat brain is colored red on a black background. a lime green human organoid sits in the top left of the brain

An image of a rat brain (red) with a grafted human brain organoid (green)

Dennis Jgamadze

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

There is no simple fix for injuries in the brain: You can’t just slap on some gauze or stick it in a splint. But scientists are working towards new treatment methods for brain damage, and last week reached another milestone. In a study published February 2 in Cell Stem Cell, researchers at the University of Pennsylvania successfully transplanted a human brain organoid into a damaged rat brain. The organoid made connections to the rest of the brain and responded to flashing light stimuli.

“This is an exciting new part of the puzzle,” says Anna Devor, a neuroscientist at Boston University who recently published separate research on organoids in mice.

Compared to other organs in the body, the brain is very intricately structured, says H. Isaac Chen, a translational neuroscientist at the University of Pennsylvania Perelman School of Medicine and coauthor of the new paper. Therefore, he explains, any treatment methods, especially transplants, need to be carefully designed. “If we’re thinking about repairing the brain or restoring function to the brain, throwing a bunch of cells in that are unordered doesn’t seem to be the best way of going about it.”

With this in mind, scientists turned to organoids as a potential solution. Organoids are three-dimensional tissue cultures grown in vitro from stem cells, which can be induced to mimic the structure of a given organ with specific growth factors and other molecules. Because organoids have a structure of their own, scientists figured they would integrate better into the brain than loose cells. Attempts to transplant human brain organoids into young mice and rats have recently proven successful, but few scientists had tried using them in adult, damaged brains.

In this case, Chen and his team suctioned out a single tiny section from each adult rat’s visual cortex. They then used a pipette tip to insert an organoid of human brain cells no bigger than a grain of sand into the empty chamber. They knew two things had to happen in order for their work to be useful for brain injury research: the organoid had to form connections with the rest of the rat’s brain, and it also had to do something functional to help the brain that it was integrated into. After letting the organoids settle, they checked on the rat’s brains every month for three months to see whether the organoid had survived and monitor how it was integrating into the rest of the brain.

As they’d hoped, more than 82 percent of the implanted organoids survived the full experiment. After the first month, it was clear the rats’ brains were vascularizing the surviving organoids, integrating them into the rest of the visual system. When Chen ran a virus tracer designed to identify cells from the grafted organoid within the rats’ eyes, he found a direct connection between the eyes and the organoid’s neurons, proving to him that the organoids worked structurally. Moreover, when the team showed the experimental rats a flashing visual stimulus, the organoids’ neurons activated, indicating they were performing a function in the visual cortex. The fact that the organoid neurons were both structurally and functionally successful despite being just a few months old was particularly exciting to Chen. “Human neurons can take a long time to mature, sometimes 9-12 months,” he explains. “It was very cool to see that we’re able to get these types of responses even at a relatively early time.”

See “Mitochondrial Metabolism Dictates Neurons’ Growth Rate

Chen emphasizes that they are still a ways away from any clinical trials. He and his team want to continue refining the structure of the organoids themselves, and get a better understanding of the specific factors that control the process of organoid integration.

Devor agrees that more work needs to be done. “Right now, we just place the organoid and then cross our fingers and say, ‘Okay, let’s just hope for the best,’” she says, “Some connectivity gets formed, but it’s not clear to understand how.” She adds that because the organoids are being added to mature brain tissue, the growth factors that would normally stimulate brain development are mostly gone. This means scientists need to find a way to add them synthetically in so that the organoid’s growth will match that of its host brain.

Although Chen says there’s no way to know how their research will turn out, he is excited for what’s to come. “[Media] like the Back to the Future movies predicted how life would be now,” he says. “Certain things we haven’t achieved yet, like flying cars, but certain things we have achieved that we didn’t even think about then. We are at the very beginning of the journey here, and there is still a lot to figure out.”

Keywords

Meet the Author

  • A black and white headshot of Katherine Irving

    Katherine Irving

    Katherine Irving is an intern at The Scientist. She studied creative writing, biology, and geology at Macalester College, where she honed her skills in journalism and podcast production and conducted research on dinosaur bones in Montana. Her work has previously been featured in Science.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio